Bruder Gerard E, Stewart Jonathan W, McGrath Patrick J, Deliyannides Deborah, Quitkin Frederic M
Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.
Neuropsychopharmacology. 2004 Sep;29(9):1752-61. doi: 10.1038/sj.npp.1300519.
Patients having a depressive disorder vary widely in their therapeutic responsiveness to a selective serotonin reuptake inhibitor (SSRI), but there are no clinical predictors of treatment outcome. Studies using dichotic listening, electrophysiologic and neuroimaging measures suggest that pretreatment differences among depressed patients in functional brain asymmetry are related to responsiveness to antidepressants. Two new studies replicate differences in dichotic listening asymmetry between fluoxetine responders and nonresponders, and demonstrate the importance of gender in this context. Right-handed outpatients who met DSM-IV criteria for major depression, dysthymia, or depression not otherwise specified were tested on dichotic fused-words and complex tones tests before completing 12 weeks of fluoxetine treatment. Perceptual asymmetry (PA) scores were compared for 75 patients (38 women) who responded to treatment and 39 patients (14 women) who were nonresponders. Normative data were also obtained for 101 healthy adults (61 women). Patients who responded to fluoxetine differed from nonresponders and healthy adults in favoring left- over right-hemisphere processing of dichotic stimuli, and this difference was dependent on gender and test. Heightened left-hemisphere advantage for dichotic words in responders was present among women but not men, whereas reduced right-hemisphere advantage for dichotic tones in responders was present among men but not women. Pretreatment PA was also predictive of change in depression severity following treatment. Responder vs nonresponder differences for verbal dichotic listening in women and nonverbal dichotic listening in men are discussed in terms of differences in cognitive function, hemispheric organization, and neurotransmitter function.
患有抑郁症的患者对选择性5-羟色胺再摄取抑制剂(SSRI)的治疗反应差异很大,但目前尚无治疗结果的临床预测指标。使用双耳分听、电生理和神经影像学测量的研究表明,抑郁症患者治疗前大脑功能不对称的差异与对抗抑郁药的反应有关。两项新研究重复了氟西汀反应者和无反应者在双耳分听不对称方面的差异,并证明了性别在此背景下的重要性。符合DSM-IV标准的重度抑郁症、心境恶劣或未另行规定的抑郁症的右利手门诊患者,在完成12周氟西汀治疗之前,接受了双耳融合词和复杂音调测试。比较了75名治疗有反应的患者(38名女性)和39名无反应的患者(14名女性)的感知不对称(PA)分数。还获得了101名健康成年人(61名女性)的标准数据。对氟西汀有反应的患者与无反应者及健康成年人不同,他们在双耳刺激的处理上更倾向于左半球而非右半球,这种差异取决于性别和测试。反应者在双耳词方面左半球优势增强在女性中存在而在男性中不存在,而反应者在双耳音调方面右半球优势减弱在男性中存在而在女性中不存在。治疗前的PA也可预测治疗后抑郁严重程度的变化。从认知功能、半球组织和神经递质功能的差异方面讨论了女性言语双耳分听和男性非言语双耳分听中反应者与无反应者的差异。